The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1plus) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment

Konference: 2014 56th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 618. Acute Lymphoblastic Leukemia: Molecular Genetic Studies

Číslo abstraktu: 131

Autoři: Elif Dagdan; MUDr. Markéta Kubričanová-Žaliová, Ph.D.; Petra Dörge, PhD; MD Anja Möricke; Martin Zimmermann, Ph.D.; Andrea Teigler-Schlegel, PhD; Prof. MD Claus R. Bartram; Dr. phil. nat. Rolf Koehler, PhD; MD Richard Ratei; Prof. Dr. med. Wolf-Dieter Ludwig; Dr. Julia Alten; Dr. med. Denis Martin Schewe; Prof. M.D. Christian Kratz; Prof. Richard S. Houlston; MD Jean-Pierre Bourquin, PhD; MD Andrea Biondi; Giovanni (Gianni) Cazzaniga, PhD; MD Giuseppe Basso; Dr. Geertruy (Gertruuy) Te Kronnie, PhD; Dr. Marie-Laure Yaspo; MD Martin Schrappe; MD Gunnar Cario; MD Martin Stanulla, MSc

Datum přednesení příspěvku: 7. 12. 2014